TMDX: TransMedics Group Inc

TMDX新闻

• Zacks 23:00 TransMedics (TMDX) Reports Q2 Earnings: What Key Metrics Have to Say
• Investing 23:00 Earnings call transcript: TransMedics beats Q2 2025 expectations with strong revenue
• Benzinga 22:19 TransMedics Group Stock Jumps On Q2 Earnings Beat, Company Raises 2025 Outlook - TransMedics Group (NASDAQ:TMDX)
• Zacks 22:05 TransMedics (TMDX) Q2 Earnings and Revenues Surpass Estimates
• Investing 21:28 TransMedics shares soar as Q2 earnings double analyst estimates
• The Motley Fool 21:06 TransMedics Sees Its Earnings Soar
• Investing 20:21 TransMedics earnings beat by $0.47, revenue topped estimates
• GuruFocus 11:33 TransMedics Q2 Preview: Organ-Flight Momentum in Focus
• Zacks 04:00 Countdown to TransMedics (TMDX) Q2 Earnings: Wall Street Forecasts for Key Metrics
• Zacks 12:03 Veracyte (VCYT) Soars 7.0%: Is Further Upside Left in the Stock?
• Seeking Alpha 15:57 Why TransMedics Stock Remains A Buy Into 2026 (NASDAQ:TMDX)
• Investing 11:26 Canaccord Genuity raises TransMedics stock price target to $142 on revenue growth
• Benzinga 11:07 Top 3 Health Care Stocks That Could Blast Off In July - RxSight (NASDAQ:RXST), Sarepta Therapeutics (NASDAQ:SRPT)
• Seeking Alpha 04:27 TransMedics: Q2 Analyst Estimates Will Fall Short (NASDAQ:TMDX)
• Investor's Business Daily 23:02 Western Digital In 9-Week Win Streak, On 2 Top Stock Watchlists: Check Out IBD 50, Stock Spotlight, Others
• Benzinga 18:37 Crude Oil Rises Sharply; Milestone Pharmaceuticals Shares Plunge - Federal Agricultural (NYSE:AGM), MiNK Therapeutics (NASDAQ:INKT)
• Investing 18:01 Visa, Mastercard lead market cap stock movers on Friday
• Seeking Alpha 14:00 Headwaters Capital Q2 2025 Investor Letter
• The Motley Fool 23:00 Is TransMedics Stock a Buy After Short-Seller Drama?
• The Motley Fool 08:21 2 Stocks That Have Doubled This Year and Are Still Worth Buying
• The Motley Fool 13:10 10 Under-the-Radar Healthcare Stocks With Incredible Growth Potential
• Investing 14:26 Cowen names Transmedics stock as top small-cap pick on transplant demand
• Seeking Alpha 14:00 TransMedics Stock’s Turnaround: The Organ Transplant Leader Is Still A Buy (NASDAQ:TMDX)
• Investing 10:51 TransMedics price target raised to $150 from $130 at Oppenheimer